Designing dendrimers for biological applications

Nature Biotechnology

Volumn 23, Issue 12, 2005, Pages 1517-1526

  Lee, Cameron C ^a   MacKay, John A ^b   Fréchet, Jean M J ^a   Szoka, Francis C ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCOMPATIBILITY; BIODEGRADATION; BIOMEDICAL ENGINEERING; MOLECULAR WEIGHT; PHARMACOKINETICS; SYNTHESIS (CHEMICAL);

OPTICAL OXYGEN SENSORS; SYNTHETIC POLYMERS;

DENDRIMERS;

10 HYDROXYCAMPTOTHECIN; ANTIVIRUS AGENT; BOLTRON; CARBOHYDRATE DERIVATIVE; CISPLATIN; DENDRIMER; DNA; DOXORUBICIN; G 2 POLY(GLUTAMIC ACID); HERLEEN; HYBRANE; INDOMETACIN; LIPID; LIPOSOME; LUPASOL; METHOTREXATE; MONOMER; OXYGEN; POLYAMIDE; POLYAMIDOAMINE; POLYAMINE DERIVATIVE; POLYESTER; POLYLYSINE; POLYMELAMINE; POLYMER; POLYOL; POLYPEPTIDE; POLYPROPYLENE; UNCLASSIFIED DRUG; VIVAGEL;

ACCURACY; BIOCOMPATIBILITY; BIODEGRADATION; BIOLOGICAL ACTIVITY; CHEMICAL COMPOSITION; COST BENEFIT ANALYSIS; CROSS LINKING; DRUG BIOAVAILABILITY; DRUG CONFORMATION; DRUG CONJUGATION; DRUG DESIGN; DRUG MANUFACTURE; DRUG RELEASE; DRUG SOLUBILITY; DRUG SYNTHESIS; HYDROPHILICITY; MOLECULAR WEIGHT; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PREDICTION; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; SENSOR; TISSUE REPAIR;

BIOCOMPATIBLE MATERIALS; BIOLOGY; DRUG DELIVERY SYSTEMS; DRUG DESIGN; GENE TRANSFER TECHNIQUES; GUIDED TISSUE REGENERATION; MATERIALS TESTING; POLYMERS; TISSUE ENGINEERING; TRANSFECTION;

EID: 28644434579     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt1171     Document Type: Review

References (94)

1. Buhleier, E., Wehner, W. & Vögtle, F. "Cascade"- and "nonskid-chain-like" syntheses of molecular cavity topologies. Synthesis (Mass.) 155-158 (1978).
2. Denkewalter, R.G., Kolc, J. & Lukasavage, W.J. Macromolecular highly branched homogeneous compound based on lysine units. US Patent 4,289,872, (1981).
3. Tomalia, D.A. et al. A new class of polymers-starburst-dendritic macromolecules. Polym. J. 17, 117-132 (1985).
4. Newkome, G.R., Yao, Z., Baker, G.R. & Gupta, V.K. Micelles. Part 1. Cascade molecules: a new approach to micelles. A [27]-arborol. J. Org. Chem. 50, 2003-2004 (1985).
5. Fréchet, J.M.J. & Tomalia, D.A. (eds.) Dendrimers and Other Dendritic Polymers. (John Wiley & Sons, Chichester, New York, USA, 2001).
6. Tomalia, D.A., Naylor, A.M. & Goddard, W.A. Starburst dendrimers: molecular-level control of size, shape, surface chemistry, topology, and flexibility from atoms to macroscopic matter. Angew. Chem. Int. Edn. Engl. 29, 138-175 (1990).
7. de Brabander-van den Berg, E.M.M. & Meijer, E.W. Poly(propylene imine) dendrimers: large-scale synthesis by hetereogeneously catalyzed hydrogenations. Angew. Chem. Int. Edn Engl. 32, 1308-1311 (1993).
8. Hawker, C.J. & Fréchet, J.M.J. Preparation of polymers with controlled molecular architecture. A new convergent approach to dendritic macromolecules. J. Am. Chem. Soc. 112, 7638-7647 (1990).
9. Sadler, K. & Tam, J.P. Peptide dendrimers: applications and synthesis. J. Biotechnol. 90, 195-229 (2002).
10. 1H NMR self-diffusion studies of dendritic aliphatic polyesters based on 2,2-bis(hydroxymeth yl)propionic acid and 1,1,1-tris(hydroxyphenyl) ethane. J. Am. Chem. Soc. 118, 6388-6395 (1996).
11. Grinstaff, M.W. Biodendrimers: new polymeric biomaterials for tissue engineering. Chemistry 8, 2838-2846 (2002).
12. Turnbull, W.B. & Stoddart, J.F. Design and synthesis of glycodendrimers. J. Biotechnol. 90, 231-255 (2002).
13. Nilsen, T.W., Grayzel, J. & Prensky, W. Dendritic nucleic acid structures. J. Theor. Biol. 187, 273-284 (1997).
14. Li, Y. et al. Controlled assembly of dendrimer-like DNA. Nat. Mater. 3, 38-42 (2004).
15. Liu, M., Kono, K. & Fréchet, J.M.J. Water-soluble dendritic unimolecular micelles: their potential as drug delivery agents. J. Control. Release 65, 121-131 (2000).
16. Stevelmans, S. et al. Synthesis, characterization, and guest-host properties of inverted unimolecular dendritic micelles. J. Am. Chem. Soc. 118, 7398-7399 (1996).
17. Mammen, M., Choi, S.K. & Whitesides, G.M. Polyvalent interactions in biological systems: implications for design and use of multivalent ligands and inhibitors. Angew. Chem. Int. Edn Engl. 37, 2754-2794 (1998).
18. Lundquist, J.J. & Toone, E.J. The cluster glycoside effect. Chem. Rev. 102, 555-578 (2002).
19. André, S., Liu, B., Gabius, H.J. & Roy, R. First demonstration of differential inhibition of lectin binding by synthetic tri- and tetravalent glycoclusters from cross-coupling of rigidified 2-propynyl lactoside. Org. Biomol. Chem. 1, 3909-3916 (2003).
20. Jiang, Y.H. et al. SPL7013 gel as a topical microbicide for prevention of vaginal transmission of SHIV89.6P in macaques. AIDS Res. Hum. Retroviruses 21, 207-213 (2005).
21. Hecht, S. & Fréchet, J.M.J. Dendritic encapsulation of function: applying nature's site isolation principle from biomimetics to materials science. Angew. Chem. Int. Edn. Engl. 40, 74-91 (2001).
22. Kojima, C., Kono, K., Maruyama, K. & Takagishi, T. Synthesis of polyamidoamine dendrimers having poly(ethylene glycol) grafts and their ability to encapsulate anticancer drugs. Bioconjug. Chem. 11, 910-917 (2000).
23. Morgan, M.T. et al. Dendritic molecular capsules for hydrophobic compounds. J. Am. Chem. Soc. 125, 15485-15489 (2003).
24. Rozhkov, V., Wilson, D. & Vinogradov, S. Phosphorescent Pd porphyrin-dendrimers: tuning core accessibility by varying the hydrophobicity of the dendritic matrix. Macromolecules 35, 1991-1993 (2002).
25. Cloninger, M.J. Biological applications of dendrimers. Curr. Opin. Chem. Biol. 6, 742-748 (2002).
26. Stiriba, S.E., Frey, H. & Haag, R. Dendritic polymers in biomedical applications: from potential to clinical use in diagnostics and therapy. Angew. Chem. Int. Edn. Engl. 41, 1329-1334 (2002).
27. Boas, U. & Heegaard, P.M.H. Dendrimers in drug research. Chem. Soc. Rev. 33, 43-63 (2004).
28. Gillies, E.R. & Fréchet, J.M.J. Dendrimers and dendritic polymers in drug delivery. Drug Discov. Today 10, 35-43 (2005).
29. Allen, T.M. & Cullis, P.R. Drug delivery systems: entering the mainstream. Science 303, 1818-1822 (2004).
30. Malik, N., Evagorou, E.G. & Duncan, R. Dendrimer-platinate: a novel approach to cancer chemotherapy. Anticancer Drugs 10, 767-776 (1999).
31. Matsumura, Y. & Maeda, H. A new concept for macromolecutar therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res. 46, 6387-6392 (1986).
32. Duncan, R. Polymer conjugates for tumour targeting and intracytoplasmic delivery. The EPR effect as a common gateway? Pharm. Sci. Technol. Today 2, 441-449 (1999).
33. Kukowska-Latallo, J.F. et al. Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer. Cancer Res. 65, 5317-5324 (2005).
34. Wooley, K.L., Hawker, C.J. & Fréchet, J.M.J. Unsymmetrical three-dimensional macromolecules: preparation and characterization of strongly dipolar dendritic macromolecules. J. Am. Chem. Soc. 115, 11496-11505 (1993).
35. Gillies, E.R. & Fréchet, J.M.J. Designing macromolecules for therapeutic applications: polyester dendrimer-poly(ethylene oxide) "bow-tie" hybrids with tunable molecular weight and architecture. J. Am. Chem. Soc. 124, 14137-14146 (2002).
36. Steffensen, M.B. & Simanek, E.E. Synthesis and manipulation of orthogonally protected dendrimers: building blocks for library synthesis. Angew. Chem. Int. Edn. Engl. 43, 5178-5180 (2004).
37. Li, Y., Cu, Y.T.H. & Luo, D. Multiplexed detection of pathogen DNA with DNA-based fluorescence nanobarcodes. Nat. Biotechnol. 23, 885-889 (2005).
38. Haensler, J. & Szoka, F.C. Polyamidoamine cascade polymers mediate efficient transfection of cells in culture. Bioconjug. Chem. 4, 372-379 (1993).
39. Tang, M.X., Redemann, C.T. & Szoka, F.C. In vitro gene delivery by degraded polyamidoamine dendrimers. Bioconjug. Chem. 7, 703-714 (1996).
40. Vincent, L. et al. Efficacy of dendrimer-mediated angiostatin and TIMP-2 gene delivery on inhibition of tumor growth and angiogenesis: in vitro and in vivo studies. Int. J. Cancer 105, 419-429 (2003).
41. Wiener, E.C. et al. Dendrimer-based metal chelates: a new class of magnetic resonance imaging contrast agents. Magn. Reson. Med. 31, 1-8 (1994).
42. Margerum, L.D. et al. Gadolinium(III) DO3A macrocycles and polyethylene glycol coupled to dendrimers. Effect of molecular weight on physical and biological properties of macromolecular magnetic resonance imaging contrast agents. J. Alloys Compd. 249, 185-190 (1997).
43. Kobayashi, H. & Brechbiel, M.W. Dendrimer-based macromolecular MRI contrast agents: characteristics and application. Mol. Imaging 2, 1-10 (2003).
44. Ziemer, L.S., Lee, W.M.F., Vinogradov, S.A., Sehgal, C. & Wilson, D.F. Oxygen distribution in murine tumors: characterization using oxygen-dependent quenching of phosphorescence. J. Appl. Physiol. 98, 1503-1510 (2005).
45. Dunphy, I., Vinogradov, S.A. & Wilson, D.F. Oxyphor R2 and G2: phosphors for measuring oxygen by oxygen-dependent quenching of phosphorescence. Anal. Biochem. 310, 191-198 (2002).
46. Briñas, R.P., Troxler, T., Hochstrasser, R.M. & Vinogradov, S.A. Phosphorescent oxygen sensor with dendritic protection and two-photon absorbing antenna. J. Am. Chem. Soc. 127, 11851-11862 (2005).
47. Supattapone, S., Nguyen, H.O.B., Cohen, F.E., Prusiner, S.B. & Scott, M.R. Elimination of prions by branched polyamines and implications for therapeutics. Proc. Natl. Acad. Sci. USA 96, 14529-14534 (1999).
48. Roy, R. & Baek, M.G. Glycodendrimers: novel glycotope isosteres unmasking sugar coding. Case study with T-antigen markers from breast cancer MUC1 glycoprotein. J. Biotechnol. 90, 291-309 (2002).
49. Bourne, N. et al. Dendrimers, a new class of candidate topical microbicides with activity against herpes simplex virus infection. Antimicrob. Agents Chemother. 44, 2471-2474 (2000).
50. Wathier, M., Jung, P.J., Camahan, M.A., Kim, T. & Grinstaff, M.W. Dendritic macromers as in situ polymerizing biomaterials for securing cataract incisions. J. Am. Chem. Soc. 126, 12744-12745 (2004).
51. Velazquez, A.J. et al. New dendritic adhesives for sutureless ophthalmic surgical procedures. In vitro studies of corneal laceration repair. Arch. Ophthalmol. 122, 867-870 (2004).
52. Drobnik, J. & Rypacek, F. Soluble synthetic polymers in biological systems. Adv. Polym. Sci. 57, 1-50 (1984).
53. Roberts, J.C., Bhalgat, M.K. & Zera, R.T. Preliminary biological evaluation of polyamidoamine (PAMAM) Starburst dendrimers. J. Biomed. Mater. Res. 30, 53-65 (1996).
54. 125l-labelled polyamidoamine dendrimers in vivo. J. Control. Release 65, 133-148 (2000).
55. Jevprasesphant, R. et al. The influence of surface modification on the cytotoxicity of PAMAM dendrimers. Int. J. Pharm. 252, 263-266 (2003).
56. De Jesús, O.L.P., Ihre, H.R., Gagne, L., Fréchet, J.M.J. & Szoka, F.C. Polyester dendritic systems for drug delivery applications: in vitro and in vivo evaluation. Bioconjug. Chem. 13, 453-461 (2002).
57. Gillies, E.R., Dy, E., Fréchet, J.M.J. & Szoka, F.C. Biological evaluation of polyester dendrimer: poly(ethylene oxide) "bow-tie" hybrids with tunable molecular weight and architecture. Mol. Pharm. 2, 129-138 (2005).
58. Fuchs, S. et al. A surface-modified dendrimer set for potential application as drug delivery vehicles: synthesis, in vitro toxicity, and intracellular localization. Chemistry 10, 1167-1192 (2004).
59. Chen, H.T., Neerman, M.F., Parrish, A.R. & Simanek, E.E. Cytotoxicity, hemolysis, and acute in vivo toxicity of dendrimers based on melamine, candidate vehicles for drug delivery. J. Am. Chem. Soc. 126, 10044-10048 (2004).
60. Hong, S. et al. Interaction of poly(amidoamine) dendrimers with supported lipid bilayers and cells: hole formation and the relation to transport. Bioconjug. Chem. 15, 774-782 (2004).
61. Kuo, J.H.S., Jan, M.S. & Chiu, H.W. Mechanism of cell death induced by cationic dendrimers in RAW 264.7 murine macrophage-like cells. J. Pharm. Pharmacol. 57, 489-495 (2005).
62. Neerman, M.F., Zhang, W., Parrish, A.R. & Simanek, E.E. In vitro and in vivo evaluation of a melamine dendrimer as a vehicle for drug delivery. Int. J. Pharm. 281, 129-132 (2004).
63. Seebach, D., Herrmann, G.F., Lengweiler, U.D., Bachmann, B.M. & Amrein, W. Synthesis and enzymatic degradation of dendrimers from (R)-3-hydroxy-butanoic acid and trimesic acid. Angew. Chem. Int. Edn. Engl. 35, 2795-2797 (1996).
64. Ihre, H.R., De Jesús, O.L.P., Szoka, F.C. & Fréchet, J.M.J. Polyester dendritic systems for drug delivery applications: design, synthesis, and characterization. Bioconjug. Chem. 13, 443-452 (2002).
65. Lee, C.C., Grayson, S.M. & Fréchet, J.M.J. Synthesis of narrow-polydispersity degradable dendronized aliphatic polyesters. J. Polym. Sci. Part A: Polym. Chem. 42, 3563-3578 (2004).
66. Zhang, W. et al. Evaluation of multivalent dendrimers based on melamine: kinetics of thiol-disulfide exchange depends on the structure of the dendrimer. J. Am. Chem. Soc. 125, 5086-5094 (2003).
67. Rendle, P.M. et al. Glycodendriproteins: a synthetic glycoprotein mimic enzyme with branched sugar-display potently inhibits bacterial aggregation. J. Am. Chem. Soc. 126, 4750-4751 (2004).
68. Córdova, A. & Janda, K.D. Synthesis and catalytic antibody functionalization of dendrimers. J. Am. Chem. Soc. 123, 8248-8259 (2001).
69. Haba, K. et al. Single-triggered trimeric prodrugs. Angew. Chem. Int. Edn. Engl. 44, 716-720 (2005).
70. Bracci, L. et al. Synthetic peptides in the form of dendrimers become resistant to protease activity. J. Biol. Chem. 278, 46590-46595 (2003).
71. Hussain, M. et al. A novel anionic dendrimer for improved cellular delivery of antisense oligonucleotides. J. Control. Release 99, 139-155 (2004).
72. Smet, M., Liao, L.X., Dehaen, W. & McGrath, D.V. Photolabile dendrimers using o-nitrobenzyl ether linkages. Org. Lett. 2, 511-513 (2000).
73. Watanabe, S., Sato, M., Sakamoto, S., Yamaguchi, K. & Iwamura, M. New dendritic caged compounds: synthesis, mass spectrometric characterization, and photochemical properties of dendrimers with á-carboxy-2-nitrobenzyl caged compounds at their periphery. J. Am. Chem. Soc. 122, 12588-12589 (2000).
74. Amir, R. J., Pessah, N., Shamis, M. & Shabat, D. Self-immolative dendrimers. Angew. Chem. Int. Edn. Engl. 42, 4494-4499 (2003).
75. Shum, P., Kim, J.M. & Thompson, D.H. Phototriggering of liposomal drug delivery systems. Adv. Drug Deliv. Rev. 53, 273-284 (2001).
76. Szalai, M.L., Kevwitch, R.M. & McGrath, D.V. Geometric disassembly of dendrimers: dendritic amplification. J. Am. Chem. Soc. 125, 15688-15689 (2003).
77. de Groot, F.M.H., Albrecht, C., Koekkoek, R., Beusker, P.H. & Scheeren, H.W. "Cascade-release dendrimers" liberate all end groups upon a single triggering event in the dendritic core. Angew. Chem. Int. Edn. Engl. 42, 4490-4494 (2003).
78. Li, S., Szalai, M.L., Kevwitch, R.M. & McGrath, D.V. Dendrimer disassembly by benzyl ether depolymerization. J. Am. Chem. Soc. 125, 10516-10517 (2003).
79. Nishikawa, M., Takakura, Y. & Hashida, M. Pharmacokinetic evaluation of polymeric carriers. Adv. Drug Deliv. Rev. 21, 135-155 (1996).
80. Yamaoka, T., Tabata, Y. & Ikada, Y. Distribution and tissue uptake of poly(ethylene glycol) with different molecular weights after intravenous administration to mice. J. Pharm. Sci. 83, 601-606 (1994).
81. Bohrer, M.P., Deen, W.M., Robertson, C.R., Troy, J.L. & Brenner, B.M. Influence of molecular configuration on the passage of macromolecules across the glomerular capillary wall. J. Gen. Physiol. 74, 583-593 (1979).
82. Ohlson, M. et al. Effects of filtration rate on the glomerular barrier and clearance of four differently shaped molecules. Am. J. Physiol. Renal Physiol. 281, F103-F113 (2001).
83. Brochard-Wyart, F. & de Gennes, P.G. Injection threshold for a star polymer inside a nanopore. C. R. l'Acadamie. Sci. Ser. II Univers 323, 473-479 (1996).
84. Lee, C.C., Yoshida, M., Fréchet, J.M.J., Dy, E.E. & Szoka, F.C. In vitro and in vivo evaluation of hydrophilic dendronized linear polymers. Bioconjug. Chem. 16, 535-541 (2005).
85. Duncan, R. The dawning era of polymer therapeutics. Nat. Rev. Drug Discov. 2, 347-360 (2003).
86. Drummond, D.C., Meyer, O., Hong, K., Kirpotin, D.B. & Papahadjopoulos, D. Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. Pharmacol. Rev. 51, 691-744 (1999).
87. King, H.D. et al. Monoclonal antibody conjugates of doxorubicin prepared with branched peptide linkers: inhibition of aggregation by methoxytriethyleneglycol chains. J. Med. Chem. 45, 4336-4343 (2002).
88. 4/N-acyl poly(ethylene glycol) prodrugs of ara-C. II. Efficacy in ascites and solid tumors. J. Control. Release 79, 55-70 (2002).
89. Pasut, G., Scaramuzza, S., Schiavon, O., Mendichi, R. & Veronese, F.M. PEG-epirubicin conjugates with high drug loading. J. Bioact. Compat. Polym. 20, 213-230 (2005).
90. Defoort, J.P., Nardelli, B., Huang, W., Ho, D.D. & Tam, J.P. Macromolecular assemblage in the design of a synthetic AIDS vaccine. Proc. Natl. Acad. Sci. USA 89, 3879-3883 (1992).
91. Voit, B. New developments in hyperbranched polymers. J. Polym. Sci. Part A: Polym. Chem. 38, 2505-2525 (2000).
92. Sunder, A., Heinemann, J. & Frey, H. Controlling the growth of polymer trees: concepts and perspectives for hyperbranched polymers. Chemistry 6, 2499-2506 (2000).
93. Schlüter, A.D. & Rabe, J.P. Dendronized polymers: synthesis, characterization, assembly at interfaces, and manipulation. Angew. Chem. Int. Edn. Engl. 39, 864-883 (2000).
94. Gössl, I., Shu, L., Schlüter, A.D. & Rabe, J.P. Molecular structure of single DNA complexes with positively charged dendronized polymers. J. Am. Chem. Soc. 124, 6860-6865 (2002).